跳至主要内容
临床试验/ISRCTN31129526
ISRCTN31129526已完成不适用

Effect of Angiotensin Converting Enzyme Inhibition (ACEI) on C-Reactive Protein (CRP) Levels: The Ramipril CRP Randomized Evaluation (4R Trial)

Sanofi-Aventis (Canada)0 个研究点目标入组 400 人开始时间: 2006年1月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 35-80 years of age, male or female, free of cardiovascular disease, and baseline CRP greater than 2 mg/l

排除标准

  • 1. Structural heart disease or vascular disease
  • 2. Systolic blood pressure greater than 160 or less than 100 mmHg
  • 3. Renal or hepatic dysfunction
  • 4. White blood cell (WBC) count greater than 12,000
  • 5. Chronic inflammatory disease
  • 6. Human Immunodeficiency Virus (HIV)
  • 7. Known sensitivity to ACEI
  • 8. Steroid use
  • 9. Chronic (more than 2 weeks) use of non-steroidal anti-inflammatory drugs (NSAIDs)
  • 10. Treatment with:
  • a. ACEI or Angiotensin II Receptor Blockers (ARB)
  • b. Lipid lowering agents
  • c. Hormone replacement therapy
  • d. Oral hypoglycemic agents
  • f. Antioxidants
  • 11. Failure to give informed consent

研究者

发起方
Sanofi-Aventis (Canada)

相似试验

已完成
3 期
The Effect of Angiotensin Convetring Enzyme Inhibitor on the Quality of Life of Non Hospitalized Patients With Cancer Cachexia in Shiraz University ClinicsGastric cancer.Malignant neoplasm of stomach
IRCT2014050511375N3Shiraz University of Midical Sciences40
招募中
不适用
Benefit and Harm of Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker in COVID-19 Patients: A Review Protocol of Systematic Review and Meta-AnalysisThere is a controversial debate regarding how to treat cardiovascular disease in COVID-19 confirmed patients. Ones documented that ACE inhibitor may increase risk of fatal COVID-19 by serving entry site for this virus, on contrary ones documented that ACEi and/or ARB may be beneficial for Acute Lung Injury and cardiovascular protection.
JPRN-UMIN000041430Faculty of Medicine, Universitas Airlangga
终止
不适用
ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty PatientsAdverse Effects of Angiotensin-converting-enzyme InhibitorsHypotension
NCT01867047Duke University59
已完成
3 期
Effect of Angiotensin-converting enzyme and ß-blockers on the prognosis of severe isolated brain traumaS06.2XDiffuse traumatic brain injurySevere isolated brain trauma.
IRCT20210514051289N1Esfahan University of Medical Sciences96
已完成
不适用
Angiotensin Converting Enzyme (ACE) inhibition for the preservation of renal function and patient survival in kidney transplantatioChronic kidney disease in renal transplant patientsUrological and Genital DiseasesChronic kidney disease
ISRCTN78129473Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute528